{"label_logits": [6.246853351593018, 0.4552418887615204, -12.85860538482666], "label_probs": [0.9969562292098999, 0.0030437649693340063, 5.02667241164545e-09], "claim": "A subclass of anti-nuclear antibodies are are anti-centromere antibodies.", "premise_source_doc_id": "Anti-nuclear_antibody", "premise_source_doc_line_num": 5, "premise_source_doc_sentence": "There are many subtypes of ANAs such as anti-Ro antibodies , anti-La antibodies , anti-Sm antibodies , anti-nRNP antibodies , anti-Scl-70 antibodies , anti-dsDNA antibodies , anti-histone antibodies , antibodies to nuclear pore complexes , anti-centromere antibodies and anti-sp100 antibodies ."}
{"label_logits": [1.104305386543274, -0.7503493428230286, -2.348832845687866], "label_probs": [0.8416423797607422, 0.13172288239002228, 0.02663475088775158], "claim": "A subclass of anti-nuclear antibodies are are anti-centromere antibodies.", "premise_source_doc_id": "Anti-centromere_antibodies", "premise_source_doc_line_num": 0, "premise_source_doc_sentence": "Anti-centromere antibodies  (  ACAs ; often styled solid , anticentromere  )  are autoantibodies specific to centromere and kinetochore function ."}
{"label_logits": [1.8231087923049927, 0.04074609652161598, -3.8023436069488525], "label_probs": [0.8533551096916199, 0.14356862008571625, 0.003076286753639579], "claim": "A subclass of anti-nuclear antibodies are are anti-centromere antibodies.", "premise_source_doc_id": "Anti-centromere_antibodies", "premise_source_doc_line_num": 8, "premise_source_doc_sentence": "Anti-centromere antibodies present early in the course of disease and are notably predictive of limited cutaneous involvement and a decreased likelihood of aggressive internal organ involvement , such as fibrosis in the lungs ."}
{"label_logits": [1.0936015844345093, -0.32509252429008484, -2.4800143241882324], "label_probs": [0.7873494625091553, 0.19056209921836853, 0.02208847925066948], "claim": "A subclass of anti-nuclear antibodies are are anti-centromere antibodies.", "premise_source_doc_id": "Anti-centromere_antibodies", "premise_source_doc_line_num": 5, "premise_source_doc_sentence": "Anti-centromere antibodies are found in approximately 60 % of patients with limited systemic scleroderma and in 15 % of those with the diffuse form of scleroderma ."}
{"label_logits": [0.34485623240470886, -0.5232188105583191, -1.9157495498657227], "label_probs": [0.6561481356620789, 0.27542394399642944, 0.0684279128909111], "claim": "A subclass of anti-nuclear antibodies are are anti-centromere antibodies.", "premise_source_doc_id": "Anti-glycoprotein-210_antibodies", "premise_source_doc_line_num": 10, "premise_source_doc_sentence": "While patients with AGPA progress toward end-stage liver failure , patients with anti-centromere antibodies often progress toward portal hypertension , further indicating a specific role of the AGPA in PBC ."}
